What is Erlotinib?

Category: Prescription Drugs

Most popular types: Tarceva

false

Erlotinib is an orally administered medication that can be used to treat locally advanced or metastatic EGFR positive non-small cell lung cancer (NSCLC). It can also be used in combination with gemcitabine as a first-line treatment for locally advanced, unresectable, or metastatic pancreatic cancer.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Adenocarcinoma (non-small cell lung cancer) 22 16
Lung cancer 4 3
Non-small cell lung cancer 3 1
Small cell lung cancer 1 1
Squamous cell carcinoma (non-small cell lung cancer) 1 0
Unclassified carcinoma (non-small cell lung cancer) 1 1

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 3
Moderate 8
Mild 11
None 0

Commonly reported side effects and conditions associated with Erlotinib

Side effect Patients
Diarrhea 10
Rash or skin problems 5
Dry skin 4
Rashes (redness, swelling) 3
Acne breakout 2
Change in hair texture 2

Show all 32 reported side effects

Dosages

Based on patients currently taking Erlotinib

Dosage Patients
150 mg daily 6
75 mg daily 2
100 mg daily 2
50 mg daily 1
125 mg daily 1

Why patients stopped taking Erlotinib

Multiple reasons could be selected

Reason Patients
Did not seem to work 2
Doctor's advice 1
Other 1
Side effects too severe 1
See all 5 patients who've stopped taking Erlotinib

Duration

Currently taking Erlotinib

Duration Patients
1 - 6 months 2
6 months - 1 year 1
1 - 2 years 2
2 - 5 years 5
5 - 10 years 1
10 years or more 2

Stopped taking Erlotinib

Duration Patients
1 - 6 months 2
1 - 2 years 3
Adherence
Adherence Evaluations
Always 20
Usually 0
Sometimes 1
Never taken as prescribed 1
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 1
A little hard to take 8
Not at all hard to take 13
Cost per month
Cost per month Evaluations
$200+ 1
$100-199 2
$50-99 2
$25-49 2
< $25 4
Not specified 11

What people switch to and from

Patients started taking Erlotinib after stopping:

Treatment Patients
Afatinib (Gilotrif) 1

Patients stopped taking Erlotinib and switched to:

Treatment Patients
Osimertinib (Tagrisso) 2
Afatinib (Gilotrif) 1
Chemotherapy 1
Last updated:
There are no evaluations for Erlotinib.